Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

December 2014

New Maine Mandate for Oral Chemotherapies


A new mandate takes effect in Maine in January that affects the member cost sharing for oral medications used to treat cancer. The new law requires insurers to cover oral chemotherapies on a basis no less favorable than coverage applied to intravenously administered or injected cancer medications.

As a result, for plans other than Best Buy HSA plans, Harvard Pilgrim will now be covering oral medications for cancer treatment obtained at a pharmacy at no charge to members. For Best Buy HSA plans, the in-network deductible that pertains to intravenously administered or injected cancer medications will also apply to oral chemotherapies.

The new mandate applies to fully-insured plans purchased or renewed on or after January 1, 2015. 

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

New Maine Mandate for Oral Chemotherapies

New Version of CAQH Coming in 2015

Medicare Advantage Provider Payments & the Sequestration Reduction

CLINICIAN CORNER

New Quantity Limit for OxyContin

How Care Management Improves Coordination Across Multiple Settings

Specialty Pharmacy Program Updates

Acupuncture Benefit Offered in 2015

Schizophrenia and the Risk of Metabolic Syndrome

PCPs and Behavioral Health Care Providers — Working Together

OFFICE ASSISTANT

Remember to Complete Your Provider Satisfaction Survey

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Contributing Writer

Kristin Edmonston,
Production Coordinator